Labcorp Holdings Inc. (LH) |
| 268.87 4.69 (1.78%) 04-14 16:00 |
| Open: | 263.855 |
| High: | 269.14 |
| Low: | 262.73 |
| Volume: | 438,027 |
| Market Cap: | 22,289(M) |
| PE Ratio: | 25.7 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Diagnostics & Research |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 324.61 |
| Resistance 1: | 277.92 |
| Pivot price: | 268.48 |
| Support 1: | 265.49 |
| Support 2: | 257.80 |
| 52w High: | 293.72 |
| 52w Low: | 209.38 |
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Financials
| EPS | 10.460 |
| Book Value | 104.860 |
| PEG Ratio | 0.00 |
| Gross Profit | 48.665 |
| Profit Margin (%) | 6.28 |
| Operating Margin (%) | 10.55 |
| Return on Assets (ttm) | 5.1 |
| Return on Equity (ttm) | 10.5 |
Company news
Tue, 14 Apr 2026
Months of Alzheimer’s data work shrink to minutes with Labcorp AI - Stock Titan
Tue, 14 Apr 2026
Labcorp Holdings Inc. $LH Shares Sold by AMI Asset Management Corp - MarketBeat
Mon, 13 Apr 2026
Labcorp Holdings Inc. $LH Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Sun, 12 Apr 2026
Illumina (ILMN), Labcorp (LH) Expand Precision Oncology NGS Collaboration - Yahoo Finance
Fri, 10 Apr 2026
Is Labcorp Holdings Inc (LH) a Bargain After 4.5% Drop? GF Value Says Undervalued - GuruFocus
Fri, 10 Apr 2026
Labcorp (NYSE: LH) posts $14B 2025 revenue and outlines 2026 proxy agenda - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
